1. Vitamin D and the Epithelial to Mesenchymal Transition.
    María Jesús Larriba et al, 2016, Stem Cells Int CrossRef
  2. null
    Mansi Manchanda et al, 2017 CrossRef
  3. Cysteine cathepsins B and X promote epithelial-mesenchymal transition of tumor cells
    Ana Mitrović et al, 2017, European Journal of Cell Biology CrossRef
  4. A micRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial–mesenchymal transition
    Yi-fan Zhao et al, 2017, Acta Pharmacol Sin CrossRef
  5. K-ras mutation promotes ionizing radiation-induced invasion and migration of lung cancer in part via the Cathepsin L/CUX1 pathway
    Long Wang et al, 2017, Experimental Cell Research CrossRef
  6. MicroRNA-152 inhibits tumor cell growth while inducing apoptosis via the transcriptional repression of cathepsin L in gastrointestinal stromal tumor
    Hong-Jie Lu et al, 2017, CBM CrossRef
  7. Palmitate impairs angiogenesis via suppression of cathepsin activity
    Jin Zhang et al, 2017 CrossRef
  8. Cathepsin L promotes ionizing radiation-induced U251 glioma cell migration and invasion through regulating the GSK-3β/CUX1 pathway
    Yao Fei et al, 2018, Cellular Signalling CrossRef
  9. Cysteine cathepsins: Their biological and molecular significance in cancer stem cells
    Pišlar Anja et al, 2018, Seminars in Cancer Biology CrossRef
  10. Novel TGF-β1 inhibitor antagonizes TGF-β1-induced epithelial-mesenchymal transition in human A549 lung cancer cells
    Ji-Hoon Jeong et al, 2018, J Cell Biochem CrossRef
  11. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor
    Liza J. Burton et al, 2017, Mol. Cell. Biol. CrossRef
  12. Timosaponin AIII inhibits metastasis of renal carcinoma cells through suppressing cathepsin C expression by AKT/miR-129-5p axis.
    Kuang-Chung Chiang et al, 2019, J Cell Physiol CrossRef
  13. Cathepsin L activated by mutant p53 and Egr-1 promotes ionizing radiation-induced EMT in human NSCLC
    Wenjuan Wang et al, 2019, J Exp Clin Cancer Res CrossRef
  14. Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells
    Mei-ling Han et al, 2016, Acta Pharmacol Sin CrossRef
  15. Cystatins in cancer progression: More than just cathepsin inhibitors.
    Barbara Breznik et al, 2019, Biochimie CrossRef
  16. The Role of Cysteine Cathepsins in Cancer Progression and Drug Resistance
    Magdalena Rudzińska et al, 2019, IJMS CrossRef
  17. Cathepsin L-mediated resistance of paclitaxel and cisplatin is mediated by distinct regulatory mechanisms
    Yifan Zhao et al, 2019, J Exp Clin Cancer Res CrossRef
  18. Lysosomal cysteine peptidases – Molecules signaling tumor cell death and survival
    Anja Pišlar et al, 2015, Seminars in Cancer Biology CrossRef
  19. The role of proteases in epithelial-to-mesenchymal cell transitions in cancer
    Julia Mitschke et al, 2019, Cancer Metastasis Rev CrossRef
  20. Clinical Impact of Cystatin C/Cathepsin L and Follistatin/Activin A Systems in Breast Cancer Progression: A Preliminary Report
    Gaetano Leto et al, 2016, Cancer Investigation CrossRef
  21. Cathepsin A regulates pluripotency, proliferation and differentiation in mouse embryonic stem cells
    Song Park et al, 2020, Cell Biochem Funct CrossRef
  22. A New TGF-β1 Inhibitor, CTI-82, Antagonizes Epithelial–Mesenchymal Transition through Inhibition of Phospho-SMAD2/3 and Phospho-ERK
    Ji-Hoon Jeong et al, 2020, Biology CrossRef
  23. Cathepsin�L interacts with CDK2‑AP1 as a potential predictor of prognosis in patients with breast cancer
    Zhan Wang et al, 2019, Oncol Lett CrossRef
  24. The potential of cystatin C as a predictive biomarker in breast cancer
    Gaetano Leto et al, 2020, Expert Review of Anticancer Therapy CrossRef
  25. Overview of Evidence-Based Chemotherapy for Oral Cancer: Focus on Drug Resistance Related to the Epithelial-Mesenchymal Transition.
    Jingjing Sha et al, 2021, Biomolecules CrossRef
  26. New insight towards development of paclitaxel and docetaxel resistance in cancer cells: EMT as a novel molecular mechanism and therapeutic possibilities.
    Milad Ashrafizadeh et al, 2021, Biomed Pharmacother CrossRef
  27. Cysteine cathepsins: structure, physiological functions and their role in carcinogenesis
    T.A. Gureeva et al, 2021, BIOMED KHIM CrossRef
  28. ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S
    Lei Yuan et al, 2022, Chemico-Biological Interactions CrossRef
  29. Lysosomal peptidases—intriguing roles in cancer progression and neurodegeneration
    Janko Kos et al, 2022, FEBS Open Bio CrossRef
  30. Cysteine Cathepsins: Structure, Physiological Functions, and the Role in Carcinogenesis
    T. A. Gureeva et al, 2022, Biochem. Moscow Suppl. Ser. B CrossRef
  31. Crosstalk between pro-survival sphingolipid metabolism and complement signaling induces inflammasome-mediated tumor metastasis
    Alhaji H. Janneh et al, 2022, Cell Reports CrossRef
  32. Prostate cancer metastasis and health disparities: a systematic review
    Yusuf Liadi et al, 2023, Prostate Cancer Prostatic Dis CrossRef
  33. New findings on the action of hypericin in hypoxic cancer cells with a focus on the modulation of side population cells
    Viktória Buľková et al, 2023, Biomedicine & Pharmacotherapy CrossRef
  34. The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
    Hao Liu et al, 2023, Front. Immunol. CrossRef
  35. Role of microRNAs in regulation of doxorubicin and paclitaxel responses in lung tumor cells
    Amirhosein Maharati et al, 2023, Cell Div CrossRef
  36. Lysosomes in Cancer—At the Crossroad of Good and Evil
    Ida Eriksson et al, 2024, Cells CrossRef
  37. Distinct effects of intravenous bone marrow-derived mesenchymal stem cell therapy on ischemic and non-ischemic lungs after ischemia-reperfusion injury
    Julia Radicetti-Silva et al, 2024, Cytotherapy CrossRef
  38. Recent discovery of natural substances with cathepsin L-inhibitory activity for cancer metastasis suppression
    Jun-Young Park et al, 2024, European Journal of Medicinal Chemistry CrossRef
  39. Lysosome-related proteins may have changes in the urinary exosomes of patients with acute gout attack
    Jitu Wang et al, 2025, Eur J Med Res CrossRef